FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1294-1296 May 11, 1995 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

Hepatocellular carcinoma is one of the most common malignant tumors in the world. It is a major cause of death from cancer in eastern Asia, especially China, Japan, Taiwan, Singapore, and Korea, and sub-Saharan Africa, particularly Zimbabwe, Ethiopia, and Mozambique.¹ The annual number of deaths worldwide is estimated to exceed 250,000. Although much less common in North America, hepatocellular carcinoma is responsible for approximately 12,000 deaths per year in the United States. About half the patients in the United States have regional or distant spread at the time of diagnosis. The five-year survival rate among white patients increased from 2 . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Li, X., Pan, Y., Fan, R., Jin, H., Han, S., Liu, J., Wu, K., Fan, D. (2008). Adenovirus-delivered CIAPIN1 small interfering RNA inhibits HCC growth in vitro and in vivo. Carcinogenesis 29: 1587-1593 [Abstract] [Full Text]  
• Ling, C.-Q., Li, B., Zhang, C., Zhu, D.-Z., Huang, X.-Q., Gu, W., Li, S.-X. (2005). Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma. Ann Oncol 16: 109-115 [Abstract] [Full Text]  
• Belnoue, E., Guettier, C., Kayibanda, M., Le Rond, S., Crain-Denoyelle, A.-M., Marchiol, C., Ziol, M., Fradelizi, D., Renia, L., Viguier, M. (2004). Regression of Established Liver Tumor Induced by Monoepitopic Peptide-Based Immunotherapy. J. Immunol. 173: 4882-4888 [Abstract] [Full Text]  
• Butterfield, L. H., Ribas, A., Meng, W. S., Dissette, V. B., Amarnani, S., Vu, H. T., Seja, E., Todd, K., Glaspy, J. A., McBride, W. H., Economou, J. S. (2003). T-Cell Responses to HLA-A*0201 Immunodominant Peptides Derived from {alpha}-Fetoprotein in Patients with Hepatocellular Cancer. Clin. Cancer Res. 9: 5902-5908 [Abstract] [Full Text]  
• Ikeda, M., Okada, S., Yamamoto, S., Sato, T., Ueno, H., Okusaka, T., Kuriyama, H., Takayasu, K., Furukawa, H., Iwata, R. (2002). Prognostic Factors in Patients with Hepatocellular Carcinoma Treated by Transcatheter Arterial Embolization. Jpn J Clin Oncol 32: 455-460 [Abstract] [Full Text]  
• Geschwind, J.-F. H., Ko, Y. H., Torbenson, M. S., Magee, C., Pedersen, P. L. (2002). Novel Therapy for Liver Cancer: Direct Intraarterial Injection of a Potent Inhibitor of ATP Production. Cancer Res. 62: 3909-3913 [Abstract] [Full Text]  
• Li, Y., Yu, D.-C., Chen, Y., Amin, P., Zhang, H., Nguyen, N., Henderson, D. R. (2001). A Hepatocellular Carcinoma-specific Adenovirus Variant, CV890, Eliminates Distant Human Liver Tumors in Combination with Doxorubicin. Cancer Res. 61: 6428-6436 [Abstract] [Full Text]  
• Uto, H., Ido, A., Moriuchi, A., Onaga, Y., Nagata, K., Onaga, M., Tahara, Y., Hori, T., Hirono, S., Hayashi, K., Tsubouchi, H. (2001). Transduction of Antisense Cyclin D1 Using Two-step Gene Transfer Inhibits the Growth of Rat Hepatoma Cells. Cancer Res. 61: 4779-4783 [Abstract] [Full Text]  
• Ido, A., Uto, H., Moriuchi, A., Nagata, K., Onaga, Y., Onaga, M., Hori, T., Hirono, S., Hayashi, K., Tamaoki, T., Tsubouchi, H. (2001). Gene Therapy Targeting for Hepatocellular Carcinoma: Selective and Enhanced Suicide Gene Expression Regulated by a Hypoxia-inducible Enhancer Linked to a Human {{alpha}}-Fetoprotein Promoter. Cancer Res. 61: 3016-3021 [Abstract] [Full Text]  
• Caturelli, E., Siena, D. A., Fusilli, S., Villani, M. R., Schiavone, G., Nardella, M., Balzano, S., Florio, F. (2000). Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma in Patients with Cirrhosis: Evaluation of Damage to Nontumorous Liver Tissue-Long-term Prospective Study. Radiology 215: 123-128 [Abstract] [Full Text]  
• Vollmer, C. M., Ribas, A., Butterfield, L. H., Dissette, V. B., Andrews, K. J., Eilber, F. C., Montejo, L. D., Chen, A. Y., Hu, B., Glaspy, J. A., McBride, W. H., Economou, J. S. (1999). p53 Selective and Nonselective Replication of an E1B-deleted Adenovirus in Hepatocellular Carcinoma. Cancer Res. 59: 4369-4374 [Abstract] [Full Text]  
• Butterfield, L. H., Koh, A., Meng, W., Vollmer, C. M., Ribas, A., Dissette, V., Lee, E., Glaspy, J. A., McBride, W. H., Economou, J. S. (1999). Generation of Human T-cell Responses to an HLA-A2.1-restricted Peptide Epitope Derived from {{alpha}}-Fetoprotein. Cancer Res. 59: 3134-3142 [Abstract] [Full Text]  
• Williams, R., Rizzi, P. (1996). Treating Small Hepatocellular Carcinomas. NEJM 334: 728-729 [Full Text]